FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037029114> ?p ?o ?g. }

• W2037029114 endingPage "410" @default.
• W2037029114 startingPage "404" @default.
• W2037029114 abstract "Based on the preclinical and phase 1 studies, prasugrel, a novel platelet ADP P2Y12 receptor blocker, may be a more potent platelet inhibitor than clopidogrel. This study compared the antiplatelet properties of prasugrel in a small subset of patients enrolled in the JUMBO trial, and compared with historic clopidogrel treated controls.Nine patients undergoing coronary stenting were randomised to one of three arms of prasugrel (40 mg loading, and 7.5 mg maintenance, n = 1; 60/10 mg, n = 4; or 60/15 mg, n = 2), or clopidogrel (300/75 mg, n = 2). Aspirin and GP IIb/IIIa inhibitors were permitted. Platelet activity was assessed at baseline, at 4, and 24 hours, and at 30 days after stent implantation in substudy participants, and compared with 124 historic controls who received clopidogrel. Independent of the loading, or maintenance dose, patients treated with prasugrel exhibited significantly more potent platelet inhibition as determined by ADP, and collagen induced aggregation, Ultegra Analyser, and surface expression of PECAM-1, GPIIb/IIIa antigen, and activity with PAC-1 antibody, GPIb, P-selectin, CD40-ligand, GP37, and thrombospondin receptor expression when compared with those treated with clopidogrel. There were no differences between antiplatelet agents with regard to vitronectin, LAMP-1, PAR-1 (intact and cleaved epitopes) thrombin receptor expression, or formation of platelet-monocyte microparticles. Expression of GPIIb antigen, vitronectin, and LAMP-3 receptor were not affected by both agents. Two patients treated with prasugrel 10 mg/daily exhibited complete inhibition of collagen induced aggregation at 30 days.At the dosing regimens chosen in the JUMBO trial, it seems that prasugrel is a more potent antiplatelet agent than clopidogrel. Two episodes of profound platelet inhibition, which are not seen with clopidogrel, raise the possibility of higher bleeding risks especially during long term prasugrel use. Whether stronger platelet inhibition will yield better clinical outcomes and/or increased bleeding remains to be determined in an ongoing comparative phase 3 superiority trial (TRITON)." @default.
• W2037029114 created "2016-06-24" @default.
• W2037029114 creator A5000582387 @default.
• W2037029114 creator A5038164864 @default.
• W2037029114 creator A5062887200 @default.
• W2037029114 creator A5074504108 @default.
• W2037029114 creator A5090987795 @default.
• W2037029114 date "2006-06-01" @default.
• W2037029114 modified "2023-10-10" @default.
• W2037029114 title "Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study" @default.
• W2037029114 cites W1480729244 @default.
• W2037029114 cites W1553345686 @default.
• W2037029114 cites W1596152628 @default.
• W2037029114 cites W190358518 @default.
• W2037029114 cites W196385150 @default.
• W2037029114 cites W1984232159 @default.
• W2037029114 cites W1993323415 @default.
• W2037029114 cites W2000923922 @default.
• W2037029114 cites W2003506380 @default.
• W2037029114 cites W2003593234 @default.
• W2037029114 cites W2019503295 @default.
• W2037029114 cites W2020249770 @default.
• W2037029114 cites W2031182983 @default.
• W2037029114 cites W2035054244 @default.
• W2037029114 cites W2044827277 @default.
• W2037029114 cites W2045837139 @default.
• W2037029114 cites W2048615527 @default.
• W2037029114 cites W2053379248 @default.
• W2037029114 cites W2057420854 @default.
• W2037029114 cites W2062345376 @default.
• W2037029114 cites W2074946880 @default.
• W2037029114 cites W2086599873 @default.
• W2037029114 cites W2088117527 @default.
• W2037029114 cites W2091112630 @default.
• W2037029114 cites W2093550243 @default.
• W2037029114 cites W2107797912 @default.
• W2037029114 cites W2110489891 @default.
• W2037029114 cites W2119951798 @default.
• W2037029114 cites W2124231871 @default.
• W2037029114 cites W2130350603 @default.
• W2037029114 cites W2152890478 @default.
• W2037029114 cites W2155964305 @default.
• W2037029114 cites W2156506897 @default.
• W2037029114 cites W2169719983 @default.
• W2037029114 cites W2200004420 @default.
• W2037029114 cites W2394602136 @default.
• W2037029114 cites W2398740437 @default.
• W2037029114 cites W2410395775 @default.
• W2037029114 cites W311320695 @default.
• W2037029114 doi "https://doi.org/10.1136/pgmj.2006.047696" @default.
• W2037029114 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2563744" @default.
• W2037029114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16754711" @default.
• W2037029114 hasPublicationYear "2006" @default.
• W2037029114 type Work @default.
• W2037029114 sameAs 2037029114 @default.
• W2037029114 citedByCount "37" @default.
• W2037029114 countsByYear W20370291142013 @default.
• W2037029114 countsByYear W20370291142014 @default.
• W2037029114 countsByYear W20370291142015 @default.
• W2037029114 countsByYear W20370291142016 @default.
• W2037029114 countsByYear W20370291142019 @default.
• W2037029114 countsByYear W20370291142020 @default.
• W2037029114 countsByYear W20370291142021 @default.
• W2037029114 countsByYear W20370291142023 @default.
• W2037029114 crossrefType "journal-article" @default.
• W2037029114 hasAuthorship W2037029114A5000582387 @default.
• W2037029114 hasAuthorship W2037029114A5038164864 @default.
• W2037029114 hasAuthorship W2037029114A5062887200 @default.
• W2037029114 hasAuthorship W2037029114A5074504108 @default.
• W2037029114 hasAuthorship W2037029114A5090987795 @default.
• W2037029114 hasBestOaLocation W20370291142 @default.
• W2037029114 hasConcept C126322002 @default.
• W2037029114 hasConcept C2777028646 @default.
• W2037029114 hasConcept C2777628954 @default.
• W2037029114 hasConcept C2777849778 @default.
• W2037029114 hasConcept C3018697912 @default.
• W2037029114 hasConcept C49059817 @default.
• W2037029114 hasConcept C71924100 @default.
• W2037029114 hasConcept C89560881 @default.
• W2037029114 hasConcept C98274493 @default.
• W2037029114 hasConceptScore W2037029114C126322002 @default.
• W2037029114 hasConceptScore W2037029114C2777028646 @default.
• W2037029114 hasConceptScore W2037029114C2777628954 @default.
• W2037029114 hasConceptScore W2037029114C2777849778 @default.
• W2037029114 hasConceptScore W2037029114C3018697912 @default.
• W2037029114 hasConceptScore W2037029114C49059817 @default.
• W2037029114 hasConceptScore W2037029114C71924100 @default.
• W2037029114 hasConceptScore W2037029114C89560881 @default.
• W2037029114 hasConceptScore W2037029114C98274493 @default.
• W2037029114 hasIssue "968" @default.
• W2037029114 hasLocation W20370291141 @default.
• W2037029114 hasLocation W20370291142 @default.
• W2037029114 hasLocation W20370291143 @default.
• W2037029114 hasLocation W20370291144 @default.
• W2037029114 hasOpenAccess W2037029114 @default.
• W2037029114 hasPrimaryLocation W20370291141 @default.
• W2037029114 hasRelatedWork W1688653807 @default.
• W2037029114 hasRelatedWork W1983666245 @default.

• next